📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

Sweden to give 12-15 year olds Pfizer vaccine, rejects Moderna

Published 10/04/2021, 10:45 AM
Updated 10/04/2021, 10:52 AM
© Reuters. Used vials of the Pfizer-BioNTech, Moderna and AstraZeneca coronavirus disease (COVID-19) vaccines are pictured at the Skane University Hospital vaccination centre in Malmo, Sweden, February 17, 2021. TT News Agency/Johan Nilsson via REUTERS ATTENTION EDI
MRNA
-

STOCKHOLM (Reuters) - Sweden's Public Health Agency said on Monday it recommended the use of Pfizer-BioNTech's, Comirnaty vaccine against COVID-19 for children between 12-15, opting against rival Moderna (NASDAQ:MRNA)'s Spikevax.

The European Medicines Agency approved the use of Comirnaty in May, while Spikevax was given the nod for children over 12 in July.

"All in all, we see reason to choose the vaccine that we know the most about and that is most well-proven when it comes to vaccinating children between 12 and 15 years of age," Anders Tegnell, head of department and state epidemiologist at the Health Agency said.

The agency said there was more data about Comirnaty's use on children.

© Reuters. Used vials of the Pfizer-BioNTech, Moderna and AstraZeneca coronavirus disease (COVID-19) vaccines are pictured at the Skane University Hospital vaccination centre in Malmo, Sweden, February 17, 2021. TT News Agency/Johan Nilsson via REUTERS ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. SWEDEN OUT. NO COMMERCIAL OR EDITORIAL SALES IN SWEDEN.

"That's why Spikevax is not recommended for the youngest age group in Sweden," the Agency said in a statement.

In September, the Agency said that children aged 12 and over would be offered a COVID vaccination starting Oct. 11.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.